Craig Parker

Craig C.
Parker was the founder of Vega Therapeutics, Inc., founded in 2009, where the title held was Chief Executive Officer from 2009 to 2011.
Current jobs include President, Chief Executive Officer & Director at Surrozen Operating, Inc. since 2018; President, Chief Executive Officer & Director at Surrozen, Inc. since 2018; Chairman-Leadership Council at the University of Michigan since 2005; and Venture Partner at The Column Group LLC since 2024.
Former jobs include Managing Director at Lehman Brothers, Inc.; Director at Gryphon Therapeutics, Inc.; Independent Director at vTv Therapeutics, Inc. from 2015 to 2019; Senior Vice President & General Manager at Immunex Corp.
from 1999 to 2001; Senior VP-Strategy & Corporate Development at Human Genome Sciences, Inc. from 2011 to 2012; EVP-Corporate Development & Scientific Affairs at Geron Corp.
in 2014; Chief Financial Officer at Proteolix, Inc. from 2012 to 2013; and Senior VP-Corporate Development at Jazz Pharmaceuticals Plc from 2014 to 2018.
Education includes an MBA from Stephen M.
Ross School of Business, an undergraduate degree from The University of Chicago conferred in 1985, and an MBA from the University of Michigan conferred in 1993.